Back to the article

HealthRX.com · Printable question sheet

Sermorelin and autoimmune disease: question sheet for your specialist

Write down your exact diagnosis, how active it is, your current treatment and why sermorelin has been suggested, then take the questions to the rheumatologist, endocrinologist or other specialist who knows your case. The facts block lists what the cited sources do and do not establish.

Companion to “Sermorelin and Autoimmune Disease: A Mechanistic Bridge Audit” · healthrx.com/sermorelin-v2/autoimmune-considerations · Facts checked 2026-10-18

Your autoimmune condition

Exact diagnosis
Current activity and date of the last flare
Organs or systems involved
Specialist who manages it

Current treatment

Include immunosuppressants, steroids, biologics, thyroid and diabetes medicines.

MedicineSchedule as prescribedStartedPrescriber

Why sermorelin has come up

Endocrine reason suggested, and the test that confirmed it
Exact product, pharmacy, concentration and route
The outcome you are hoping for

What the cited sources establish

  • A review of chronic inflammation reports that the GH/IGF-1 axis has both pro-inflammatory and anti-inflammatory effects.[1]
  • Receptors for GHRH, growth hormone and IGF-I are found on immune cells, but GH-deficient patients have shown no clinically significant immunodeficiency.[2]
  • In Graves' disease, activating antibodies against the IGF-I receptor have been detected.[3]
  • FDA withdrew approval of the Geref sermorelin products effective June 18, 2009.[4]
  • FDA does not check compounded drugs for safety, effectiveness or quality before they are sold.[5]

Questions for the specialist

  1. Is my disease active now, and which measures would show it changing?
  2. How was the growth hormone problem diagnosed, and does it meet a recognized definition?
  3. Do any of my immune, steroid, thyroid or diabetes medicines change the picture?
  4. Which symptoms or results would make us stop and reassess?
  5. Which treatments with direct evidence for my diagnosis should come first?
Sources for the facts on this sheet
  1. Witkowska-Sędek E, Pyrżak B. Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis. Cent Eur J Immunol 2020. PMID 33613096. https://pubmed.ncbi.nlm.nih.gov/33613096/
  2. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 1995. PMID 8548046. https://pubmed.ncbi.nlm.nih.gov/8548046/
  3. Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?. Pharmacol Rev 2010. PMID 20392809. https://pubmed.ncbi.nlm.nih.gov/20392809/
  4. U.S. Food and Drug Administration, Federal Register. Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Accessed 2026-10-18. https://www.federalregister.gov/documents/2013/03/04/2013-04827/determination-that-geref-sermorelin-acetate-injection-05-milligrams-basevial-and-10-milligrams
  5. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Accessed 2026-10-18. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.